Leukemia, Myelomonocytic, Acute - 25 Studies Found
Active, not recruiting |
: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Completed |
: Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia :
|
Active, not recruiting |
: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia :
|
Completed |
: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia :
|
Active, not recruiting |
: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia :
|